Sterol biosynthesis regulates TLR signaling and the innate immune response in a Smith-Lemli-Opitz syndrome model
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:134 |
|---|---|
| Enthalten in: |
The Journal of clinical investigation - 134(2024), 6 vom: 18. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gabor, Kristin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
97C5T2UQ7J |
|---|
| Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1172/JCI167633 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367271591 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367271591 | ||
| 003 | DE-627 | ||
| 005 | 20240318234101.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240119s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1172/JCI167633 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1334.xml |
| 035 | |a (DE-627)NLM367271591 | ||
| 035 | |a (NLM)38236648 | ||
| 035 | |a (PII)e167633 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gabor, Kristin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sterol biosynthesis regulates TLR signaling and the innate immune response in a Smith-Lemli-Opitz syndrome model |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2024 | ||
| 500 | |a Date Revised 18.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cholesterol | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a Innate immunity | |
| 650 | 4 | |a Lipid rafts | |
| 650 | 7 | |a Cholesterol |2 NLM | |
| 650 | 7 | |a 97C5T2UQ7J |2 NLM | |
| 700 | 1 | |a Mesev, Emily V |e verfasserin |4 aut | |
| 700 | 1 | |a Madenspacher, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Meacham, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Rai, Prashant |e verfasserin |4 aut | |
| 700 | 1 | |a Moon, Sookjin |e verfasserin |4 aut | |
| 700 | 1 | |a Wassif, Christopher A |e verfasserin |4 aut | |
| 700 | 1 | |a Shaikh, Saame Raza |e verfasserin |4 aut | |
| 700 | 1 | |a Tucker, C J |e verfasserin |4 aut | |
| 700 | 1 | |a Karmaus, Peer |e verfasserin |4 aut | |
| 700 | 1 | |a Bianconi, Simona |e verfasserin |4 aut | |
| 700 | 1 | |a Porter, Forbes D |e verfasserin |4 aut | |
| 700 | 1 | |a Fessler, Michael B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of clinical investigation |d 1924 |g 134(2024), 6 vom: 18. Jan. |w (DE-627)NLM000005487 |x 1558-8238 |7 nnns |
| 773 | 1 | 8 | |g volume:134 |g year:2024 |g number:6 |g day:18 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1172/JCI167633 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 134 |j 2024 |e 6 |b 18 |c 01 | ||